The Angiogenic Activity of Ascites in the Course of Ovarian Cancer as a Marker of Disease Progression

被引:12
|
作者
Gawrychowski, Krzysztof [1 ]
Szewczyk, Grzegorz [2 ,3 ]
Skopinska-Rozewska, Ewa [4 ]
Malecki, Maciej [5 ,6 ]
Barcz, Ewa [7 ]
Kaminski, Pawel [7 ]
Miedzinska-Maciejewska, Magdalena [8 ]
Smiertka, Waclaw [9 ]
Szukiewicz, Dariusz [3 ]
Skopinski, Piotr [10 ]
机构
[1] Medicover Hosp, Dept Gynecol Oncol & Oncol, PL-02972 Warsaw, Poland
[2] Inst Mother & Child Hlth, Dept Obstet & Gynecol, PL-01211 Warsaw, Poland
[3] Med Univ Warsaw, Dept Gen & Expt Pathol, PL-02106 Warsaw, Poland
[4] Med Univ Warsaw, Ctr Biostruct Res, Dept Pathol, PL-02004 Warsaw, Poland
[5] Med Univ Warsaw, Dept Appl Pharm & Bioengn, Warsaw, Poland
[6] Inst Mother & Child Hlth, PL-01211 Warsaw, Poland
[7] Med Univ Warsaw, Dept Obstet & Gynecol 1, PL-02015 Warsaw, Poland
[8] Holy Family Hosp, Dept Surg Oncol, PL-02544 Warsaw, Poland
[9] Natl Inst Oncol, Dept Oncol, PL-02034 Warsaw, Poland
[10] Med Univ Warsaw, Ctr Biostruct Res, Dept Histol & Embryol, PL-02004 Warsaw, Poland
关键词
VASCULAR-PERMEABILITY FACTOR; EPITHELIAL OVARIAN; GROWTH; INTERLEUKIN-8; BEVACIZUMAB; TRIAL; CELLS;
D O I
10.1155/2014/683757
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Ovarian cancer cells are able to create invasive implants in the peritoneum and their growth is directly associated with the angiogenetic potential. This effect is probably stimulated by vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8), which are both found in ascites. The aim of this study was to assess the influence of ascites produced by ovarian cancer on the angiogenesis. Peritoneal fluid was collected from patients with advanced ovarian cancer; cancer cells were separated from CD45+ leukocytes. Angiogenesis was assessed in mice, after intradermal injection of full cellular suspension together with supernatant or phosphate buffered saline, purified cancer cells suspension, or CD45+ leukocytes suspension. The angiogenesis index (AI) was assessed after 72 hours. VEGF and Il-8 were measured in the supernatant and cellular suspension. AI was the highest in the isolated cancer cells suspensions as well in the group stimulated with supernatant. Both VEGF and IL-8 were high in supernatants from ascites rich in cancer cells (>45%). A significant correlation was revealed between IL-8 concentration and AI. We conclude that ascites in patients with advanced ovarian cancer stimulates angiogenesis and this mechanism is dependent mostly on cancer cells activity and enhanced by cooperation with infiltrating leukocytes.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Angiogenic activity and interleukin-8 content of human ovarian cancer ascites
    Gawrychowski, K
    Skopinska-Rozewska, E
    Barcz, E
    Sommer, E
    Szaniawska, B
    Roszkowska-Purska, K
    Janik, P
    Zielinski, J
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1998, 19 (03) : 262 - 264
  • [2] A rare case of pseudochylous ascites in the course of ovarian cancer
    Ksiezakowska-Lakoma, Kinga
    Slodki, Maciej
    Brzezinski, Marek
    GINEKOLOGIA POLSKA, 2025, 96 (01) : 72 - 73
  • [3] Ovarian cancer ascites proteomic profile reflects metabolic changes during disease progression
    Almeida-Nunes, Diana Luisa
    Nunes, Mariana
    Osorio, Hugo
    Ferreira, Veronica
    Lobo, Claudia
    Monteiro, Paula
    Abreu, Miguel Henriques
    Bartosch, Carla
    Silvestre, Ricardo
    Dinis-Oliveira, Ricardo Jorge
    Ricardo, Sara
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2024, 39
  • [4] Potential new marker for ovarian cancer progression
    Kerr, C
    LANCET ONCOLOGY, 2002, 3 (06): : 327 - 327
  • [5] CA-125 - MARKER OF OVARIAN-CANCER OR ASCITES
    BERGMANN, JF
    BIDART, JM
    GEORGE, M
    BEAUGRAND, M
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1987, 11 (2BIS): : A215 - A215
  • [6] Paraneoplastic autoimmune hemolytic anemia in ovarian cancer: a marker of disease activity
    Loh, Kah Poh
    Kansagra, Ankit
    Asik, Armen
    Ali, Syed
    Dahiya, Saurabh
    RARE TUMORS, 2015, 7 (01) : 4 - 7
  • [7] Aberrant angiogenic signaling pathways: Accomplices in ovarian cancer progression and treatment
    Zhou, Wenchao
    Zeng, Tian
    Chen, Junling
    Tang, Xing
    Yuan, Yuwei
    Hu, Daopu
    Zhang, Yue
    Li, Yukun
    Zou, Juan
    CELLULAR SIGNALLING, 2024, 120
  • [8] Development of a prognostically relevant "angiogenic signature" in ascites from patients with advanced ovarian cancer
    Trachana, S. P.
    Gavalas, N. G.
    Pilalis, E.
    Papatheodorou, A.
    Chatziioannou, A.
    Papadodima, O.
    Terpos, E.
    Dimopoulos, M. A.
    Bamias, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S716 - S716
  • [9] The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling
    Trachana, Sofia-Paraskevi
    Pilalis, Eleftherios
    Gavalas, Nikos G.
    Tzannis, Kimon
    Papadodima, Olga
    Liontos, Michalis
    Rodolakis, Alexandros
    Vlachos, Georgios
    Thomakos, Nikolaos
    Haidopoulos, Dimitrios
    Lykka, Maria
    Koutsoukos, Konstantinos
    Kostouros, Efthimios
    Terpos, Evagelos
    Chatziioannou, Aristotelis
    Dimopoulos, Meletios-Athanasios
    Bamias, Aristotelis
    PLOS ONE, 2016, 11 (06):
  • [10] Development of a prognostically relevant 'angiogenic signature' in ascites from patients with advanced ovarian cancer
    Gavalas, N. G.
    Trachana, S. -P.
    Pilalis, E.
    Chatziioannou, A.
    Papadodima, O.
    Terpos, E.
    Dimopoulos, M. A.
    Bamias, A.
    IMMUNOLOGY, 2014, 143 : 163 - 163